Getting Questioned by the ASX??
was anyone aware of this
In assessing efficacy data they can comment but would have to seek input
from an external agency with expertise (Note: their internal expert Dr Stewart
Jessamine who helped design LCTs clinical trials died in early 2019).
lots of concern in the letter, since May the Board have been discussing making another submission???
be interesting if the ASX ask more questions, I would say the ASX have received multiple inquiries to actually then take action..
Ann: Response to ASX Aware Query, page-2
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
-0.001(12.5%) |
Mkt cap ! $11.81M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.8¢ | 0.7¢ | $21.26K | 3.022M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 8514049 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 1168300 | 11 |
View Market Depth
| Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |